Richard L. Cassin Publisher and Editor
Andy Spalding Senior Editor
Jessica Tillipman Senior Editor
Elizabeth K. Spahn Contributing Editor
Eric Carlson Contributing Editor
Benjamin Kessler Contributing Editor
Michael Kuria Contributing Editor
Thomas Fox Contributing Editor
Philip Fitzgerald Contributing Editor
Marc Alain Bohn Contributing Editor
Michael Scher Contributing Editor
Bill Waite Contributing Editor
Shruti J. Shah Contributing Editor
Dr. Henry Wong Contributing Editor
Russell A. Stamets Contributing Editor
Mark R. Friedman Contributing Editor
Andrew Reichardt Editorial Intern
Richard L. Cassin | Thursday, March 14, 2013 at 7:28AM 
ProPublica ran an exposé this week about big bucks for doctors who promote products for drug companies.
Richard L. Cassin | Monday, February 25, 2013 at 6:22AM 
Benjamin Kessler | Monday, February 4, 2013 at 6:02AM 
Authorities in Guangdong Province are responding with special seriousness to industry-wide anti-corruption regulations issued by the Ministry of Health (MOH) in July 2012.
Richard L. Cassin | Friday, January 4, 2013 at 4:18AM 
On his great Conflict of Interest Blog, Jeff Kaplan posted the ten biggest U.S. corporate criminal fines of all time.
Richard L. Cassin | Wednesday, January 2, 2013 at 4:32AM 
Twelve companies settled FCPA enforcement actions in 2012 by paying a total of $259.4 million.
Richard L. Cassin | Thursday, December 20, 2012 at 5:38PM 
Eli Lilly and Company resolved FCPA civil charges brought by the Securities and Exchange Commission based on bribes to government officials in Russia, Brazil, China, and Poland.
